Evaluation of the safety and efficacy of semiconductor laser irradiation at Guanyuan point in the treatment of primary dysmenorrhea: a randomized, double-blind, placebo-controlled trial

anjing Drum Tower Hospital The Affiliated Hospital Of Nanjing University Medical School0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Diagnosed as primary dysmenorrhea according to the primary dysmenorrhea management guidelines issued by the Society of Obstetricians and Gynecologists of Canadian in 2017;
•2. Females aged 18 to 30 years who have not given birth;
•3. Menstrual cycle regularity: 28±7 days;
•4. Periodic pain during menstruation for 6 months and above;
•5. The average pain score of the Visual Analogue Scale (VAS) of the last 3 menstrual cycles is >=4 points;
•6. Volunteer to participate in the trial and sign an informed consent form.

•1. Patients with secondary dysmenorrhea caused by gynecological diseases such as endometriosis, pelvic inflammatory disease, adenomyosis or other diseases confirmed by gynecological examination and B-ultrasound;
•2. Oral contraceptives or drugs that act on the central nervous system within 1 month before treatment, or have received relevant physical therapy;
•3. Are participating in or have participated in other drugs or other types of clinical trials within the past 1 month;
•4. There are abnormalities such as ulceration and infection in the skin of the irradiation site;
•5. Suffering from severe mental or other diseases, unable to correctly score the pain or unable to objectively describe the symptoms;
•6. History of phototherapy allergy;
•7. Women who are pregnant, breastfeeding or planning to become pregnant;
•8. There are objections to the treatment of this trial or the inability to receive regular follow-ups.

发起方

anjing Drum Tower Hospital The Affiliated Hospital Of Nanjing University Medical School